Clinical Trials on Positive Axillary Lymph Node in France

Total 233 results

Baxter Healthcare Corporation

Completed

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Breast Cancer | Lumpectomy | Mastectomy Plus Axillary Lymph Node Dissection | Lymphatic Leakage

Germany, Austria, France, Italy
Assistance Publique - Hôpitaux de Paris

Completed

Positron Emission Tomography in Extrapulmonary Tuberculosis (TUBOGTEP)

Extrapulmonary Tuberculosis | Lymph Node Tuberculosis | Bone Tuberculosis

France
Centre Hospitalier Intercommunal Creteil

Active, not recruiting

Prospective Study on the Efficacy of Exclusive Odontological and Medical Treatment in Chronic Dental Maxillary Sinusitis (DENTASINUS)

Chronic Maxillary Sinusitis

France
Centre Hospitalier Universitaire, Amiens

Completed

Evolution of Indications for Transbronchial Ganglionic Ultrasound (EBUSPicardie)

Lymph Node Disease | Transbronchial Surgery

France
GCS Ramsay Santé pour l'Enseignement et la Recherche

Recruiting

Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer. (FLUOBREAST-2)

Sentinel Lymph Node

France
Centre Hospitalier Universitaire de Besancon

Unknown

Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology (UNMASK)

Colon Cancer | Sentinel Node | Lymph Node

France
Hospices Civils de Lyon

Unknown

Measurement of Antibodies in Adults With a History of Kawasaki Disease (KAWASAKI Ac)

Kawasaki Disease

France
Foundation for Liver Research
Cook Ireland, Ltd.

Completed

Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS (ASPRO)

Pancreatic Masses | Lymph Nodes

France, Sweden, Israel, Belgium, Australia, United States, Italy, Japan, Netherlands, Spain
Poitiers University Hospital

Completed

Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

High Grade Lymphomas CD20 Positive

France
Hospices Civils de Lyon
Novartis

Unknown

Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients (PETALs)

Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Chronic Myeloid Leukemia

France
Novartis Pharmaceuticals

Completed

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Chronic Myeloid Leukemia

France
Hopital Lariboisière

Completed

Labial Biopsy in Patients With Tuberculosis Disease

Tuberculosis | Sarcoidosis

France
Poitiers University Hospital
Novartis

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
Bristol-Myers Squibb

Completed

A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting

Chronic Myeloid Leukemia

France
University Hospital, Bordeaux
Bordeaux PharmacoEpi

Completed

Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach (ECOSTIM)

Hematologic Diseases | Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis; Roche Pharma AG; Ministry of Health, France

Completed

STI571 ProspectIve RandomIzed Trial: SPIRIT (SPIRIT)

Chronic Myeloid Leukemia

France
Hospices Civils de Lyon

Completed

Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease (Kawasaki)

Kawasaki Disease

France
Assistance Publique - Hôpitaux de Paris
Swedish Orphan Biovitrum

Completed

Anakinra and Kawasaki Disease (KAWAKINRA)

Children | Kawasaki Disease

France
Novartis Pharmaceuticals

Completed

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Germany, Canada, France, Spain, Italy
Assistance Publique - Hôpitaux de Paris

Recruiting

MoMa Signature During Granulomatosis (MOSAR)

Tuberculosis | Sarcoidosis

France
University Hospital, Angers

Active, not recruiting

Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality (PALERMO)

Chronic Myeloid Leukemia (CML)

France
Institut Bergonié
Novartis

Terminated

Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response (MIM)

Leukemia, Myeloid, Chronic-Phase

France
Assistance Publique - Hôpitaux de Paris
Swedish Orphan Biovitrum

Recruiting

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment (ANACOMP)

Kawasaki Disease

France
Hospital Moinhos de Vento

Completed

Clinical Trial Comparing Carnoy's and GEWF Solutions

Colorectal Cancer | Lymph Node Metastasis

Brazil
Hybrigenics Corporation

Unknown

Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study (ICT10)

CML, Chronic Phase

France
Institut Bergonié

Recruiting

Regional Central Database Recording of Chronic Myeloid Leukemia (LMC)

Chronic Myeloid Leukemia

France
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
Poitiers University Hospital

Completed

Glivec in Pediatric Chronic Myeloid Leukemia (CML)

Chronic Myeloid Leukemia

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor (PAMIR01)

Chronic Leukemia

France
Centre Hospitalier Universitaire de Besancon

Completed

Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML) (CAR-LMC)

Chronic Myeloid Leukemia

France
University Hospital, Angers

Completed

Vascular Dysfunction and Antiangiogenic Therapy (DYVA-AAGG)

Solid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)

France
Laurent BRUNAUD

Recruiting

Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors (TEGRELE)

Neuroendocrine Tumors | Small Intestinal NET | Lymph Node Metastasis

France
University Hospital, Bordeaux

Recruiting

CML Pediatric ITK Response According to Molecular Identification at Diagnosis (CML Piramid)

Chronic Myeloid Leukemia

France
University Hospital, Toulouse
Institut National de la Santé Et de la Recherche Médicale, France

Active, not recruiting

Deciphering the Role of Circular RNAs in ALKpositive Anaplastic Large-cell Lymphoma (CIRComa)

ALK-Positive Anaplastic Large Cell Lymphoma

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia (PHARM-LMC)

Chronic Myeloid Leukemia

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. (TIPHI)

Leukemia | Chronic Leukemia | Myelogenous Leukemia | BCR-ABL Positive Acute Myeloid Leukemia

France
Novartis Pharmaceuticals

Completed

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Philadelphia Chromosome Positive CML

United States, Germany, Italy, France
Poitiers University Hospital

Active, not recruiting

Innate T Cells and TKI Discontinuation (TIBIOP-LMC)

Chronic Myeloid Leukemia

France
University Medical Center Groningen
NRG Oncology; Dutch Cancer Society

Recruiting

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII)

Vulvar Cancer | Sentinel Lymph Node | Lymph Node Metastases

United States, Netherlands
Novartis Pharmaceuticals

Recruiting

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France (ASSURE-3)

Chronic Myeloid Leukemia

France
Institut Bergonié
Novartis

Terminated

Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response (AFR22)

Myeloid Leukemia, Chronic

France
Versailles Hospital
University Hospital, Bordeaux; Maisonneuve-Rosemont Hospital

Completed

OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy) (OPTIM-DASA)

Chronic Myelogenous Leukemia, BCR/ABL Positive

France, Canada
Versailles Hospital
Pr Philippe ROUSSELOT

Unknown

Second STOP After Pioglitazone Priming in CML Patients (PIO2STOP)

Chronic Myeloid Leukemia (CML)

France
Hospices Civils de Lyon

Completed

Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia (NILOPEG)

Chronic Myelogenous Leukemia

France
Central Hospital, Nancy, France

Not yet recruiting

Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases

Myocarditis | Kawasaki Disease | Pediatric Inflammatory Multisystem Syndrome

France
University Hospital, Brest

Unknown

Ultrasonographic Comparison of Gastric Volume After Three Modes of Positive Facemask During Induction of Anaesthesia (UGV)

Positive-Pressure Respiration | Respiratory Aspiration of Gastric Content

France
Versailles Hospital

Completed

Pioglityazone and Imatinib for CML Patients (ACTIM)

Leukemia, Myeloid, Chronic-Phase

France
Assistance Publique - Hôpitaux de Paris

Recruiting

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults (GRAAPH2014)

Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia

France

3

Subscribe